NCT01598961

Brief Summary

There have been reports of monitoring LSR during MVD surgery helps predicting the clinical outcome of MVD.However, there have been no evidence of which degree of partial neuromuscular blockade should be performed or no neuromuscular blockade could be performed during LSR monitoring. Therefore, we performed a randomized controlled trial to evaluate the effect of different degree of partial neuromuscular blockade, including no neuromuscular blockade on the LSR monitoring for MVD surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started May 2012

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2012

Completed
11 days until next milestone

First Submitted

Initial submission to the registry

May 12, 2012

Completed
3 days until next milestone

First Posted

Study publicly available on registry

May 15, 2012

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2013

Completed
Last Updated

December 25, 2013

Status Verified

December 1, 2013

Enrollment Period

11 months

First QC Date

May 12, 2012

Last Update Submit

December 24, 2013

Conditions

Outcome Measures

Primary Outcomes (6)

  • Lateral spread response

    Lateral spread response of electromyography measured by electrophysiologist at baseline (30 min after anesthetic induction)

    baseline (30 min after anesthetic induction)

  • Lateral spread response

    Lateral spread response of electromyography measured by electrophysiologist before dura opening

    before dura opening (45 minute after anesthetic induction)

  • Lateral spread response

    Lateral spread response of electromyography measured by electrophysiologist after dura opening (one hour after anesthetic induction)

    after dura opening (60 min after anesthetic induction)

  • Lateral spread response

    Lateral spread response of electromyography measured by electrophysiologist before facial nerve decompression (90 minutes after anesthetic induction)

    before facial nerve decompression (90 minutes after anesthetic induction)

  • Lateral spread response

    Lateral spread response of electromyography measured by electrophysiologist after facial nerve decompression (2 hour after anesthetic induction)

    after facial nerve decompression (120 min after anesthetic induction)

  • Lateral spread response

    Lateral spread response of electromyography measured by electrophysiologist after dura closure (150 min after anesthetic induction)

    after dura closure (150 min after anesthetic induction)

Secondary Outcomes (6)

  • Train-of-four response

    Baseline (30min), Before dura open (45 min), After dura open (60 min), Before decompression (90 min), After decompression (120 min), After dura close (150 min after anesthetic induction)

  • T1/Tc amplitude

    Baseline (30min), Before dura open (45 min), After dura open (60 min), Before decompression (90 min), After decompression (120 min), After dura close (150 min after anesthetic induction)

  • incidence of patients' spontaneous movements or respiration

    Baseline (30min), Before dura open (45 min), After dura open (60 min), Before decompression (90 min), After decompression (120 min), After dura close (150 min after anesthetic induction)

  • Mean blood pressure (mmHg)

    Baseline (30min), Before dura open (45 min), After dura open (60 min), Before decompression (90 min), After decompression (120 min), After dura close (150 min after anesthetic induction)

  • heart rate (beats/min)

    Baseline (30min), Before dura open (45 min), After dura open (60 min), Before decompression (90 min), After decompression (120 min), After dura close (150 min after anesthetic induction)

  • +1 more secondary outcomes

Study Arms (3)

TOF count-guided group

ACTIVE COMPARATOR

Using partial neuromuscular blockade to maintain train-of-four response of two, TOF response measured by the neuromuscular transmission module (NMT module)

Other: TOF count-guided partial NMB

T1/Tc amplitude group

ACTIVE COMPARATOR

Using partial neuromuscular blockade to maintain T1/Tc amplitude of 50%, T1/Tc amplitude measured by the neuromuscular transmission module (NMT)

Other: T1/Tc guided partial NMB

No neuromuscular blockade group

EXPERIMENTAL

to maintain no neuromuscular blockade during LSR monitoring except the intubation dose during anesthetic induction

Other: No NMB

Interventions

Using partial neuromuscular blockade to maintain train-of-four response of two, TOF response measured by the neuromuscular transmission module (NMT module)

TOF count-guided group

Using partial neuromuscular blockade to maintain T1/Tc amplitude of 50%, T1/Tc amplitude measured by the neuromuscular transmission module (NMT)

T1/Tc amplitude group
No NMBOTHER

to maintain no neuromuscular blockade during LSR monitoring except the intubation dose during anesthetic induction

No neuromuscular blockade group

Eligibility Criteria

Age20 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Those who undergo microvascular decompression by diagnosis of hemifacial spasm in our institution

You may not qualify if:

  • Patients were excluded from the study if they had any of following: severe cardiopulmonary disorder with hemodynamic unstability (pulmonary hypertension, cardiomyopathy, mechanical ventilation, American Society of Anesthesiologists physical status III or more), severe hepatic or renal disease.
  • Those who can not undergo MEP monitoring due to central or peripheral neuromuscular disease, e.g. cerebral palsy, myasthenia gravis, acute spinal injury, neurologic shock

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Samsung Medical Center

Seoul, Gangnam-Gu, 135-710, South Korea

Location

MeSH Terms

Conditions

Hemifacial Spasm

Condition Hierarchy (Ancestors)

Mouth DiseasesStomatognathic DiseasesSpasmNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Jeong Jin Lee, MD, PhD

    Samsung Medical Center

    PRINCIPAL INVESTIGATOR
  • Won Ho Kim, MD

    Samsung Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

May 12, 2012

First Posted

May 15, 2012

Study Start

May 1, 2012

Primary Completion

April 1, 2013

Study Completion

April 1, 2013

Last Updated

December 25, 2013

Record last verified: 2013-12

Locations